Back to Search Start Over

Deconstructing tumor heterogeneity: the stromal perspective.

Authors :
Vickman RE
Faget DV
Beachy P
Beebe D
Bhowmick NA
Cukierman E
Deng WM
Granneman JG
Hildesheim J
Kalluri R
Lau KS
Lengyel E
Lundeberg J
Moscat J
Nelson PS
Pietras K
Politi K
Puré E
Scherz-Shouval R
Sherman MH
Tuveson D
Weeraratna AT
White RM
Wong MH
Woodhouse EC
Zheng Y
Hayward SW
Stewart SA
Source :
Oncotarget [Oncotarget] 2020 Oct 06; Vol. 11 (40), pp. 3621-3632. Date of Electronic Publication: 2020 Oct 06 (Print Publication: 2020).
Publication Year :
2020

Abstract

Significant advances have been made towards understanding the role of immune cell-tumor interplay in either suppressing or promoting tumor growth, progression, and recurrence, however, the roles of additional stromal elements, cell types and/or cell states remain ill-defined. The overarching goal of this NCI-sponsored workshop was to highlight and integrate the critical functions of non-immune stromal components in regulating tumor heterogeneity and its impact on tumor initiation, progression, and resistance to therapy. The workshop explored the opposing roles of tumor supportive versus suppressive stroma and how cellular composition and function may be altered during disease progression. It also highlighted microenvironment-centered mechanisms dictating indolence or aggressiveness of early lesions and how spatial geography impacts stromal attributes and function. The prognostic and therapeutic implications as well as potential vulnerabilities within the heterogeneous tumor microenvironment were also discussed. These broad topics were included in this workshop as an effort to identify current challenges and knowledge gaps in the field.<br />Competing Interests: CONFLICTS OF INTEREST Authors have no conflicts of interest to declare.<br /> (Copyright: © 2020 Vickman et al.)

Details

Language :
English
ISSN :
1949-2553
Volume :
11
Issue :
40
Database :
MEDLINE
Journal :
Oncotarget
Publication Type :
Academic Journal
Accession number :
33088423
Full Text :
https://doi.org/10.18632/oncotarget.27736